Guobang Pharma Ltd (605507) — Cash Flow Reinvestment Rate
Guobang Pharma Ltd (605507) has a Cash Flow Reinvestment Rate of 0.36x as of September 2025, reinvesting CN¥110.58 Million (capex CN¥110.58 Million ) from operating cash flow of CN¥311.27 Million. See Guobang Pharma Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guobang Pharma Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Guobang Pharma Ltd across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Guobang Pharma Ltd.
Annual Cash Flow Reinvestment Rate for Guobang Pharma Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Guobang Pharma Ltd. See financial flexibility index of Guobang Pharma Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.57x | CN¥875.56 Million | CN¥559.28 Million | CN¥277.71 Million | ▲ +108.0% |
| 2024 | 0.75x | CN¥531.80 Million | CN¥706.41 Million | CN¥419.12 Million | ▼ -64.9% |
| 2023 | 2.15x | CN¥1.11 Billion | CN¥516.76 Million | CN¥748.44 Million | ▲ +79.8% |
| 2022 | 1.19x | CN¥1.21 Billion | CN¥1.02 Billion | CN¥803.12 Million | ▲ +3.6% |
| 2020 | 1.15x | CN¥885.39 Million | CN¥767.70 Million | CN¥520.16 Million | ▼ -44.3% |
| 2019 | 2.07x | CN¥912.52 Million | CN¥440.86 Million | CN¥605.18 Million | ▲ +586.8% |
| 2018 | 0.30x | CN¥163.24 Million | CN¥541.68 Million | CN¥163.24 Million | ▼ -73.7% |
| 2017 | 1.14x | CN¥169.48 Million | CN¥148.03 Million | CN¥169.48 Million | — |